Skip to main content
Caplight Logo









eNeura

eNeura

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://eneura.com/

Last Round

Series D

Feb 6, 2018

Total Funding Raised

$62.38M

Company Overview

eNeura is a medical technology company that has developed a portable, non-invasive transcranial magnetic stimulation device for the treatment and prevention of migraines.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Patient Engagement, Health IoT

Business Model

B2C

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

migraine treatmentsTMStranscranial magnetic stimulationneuromodulationmigraine preventiondrug-free migraine therapyTMS therapyat-home medical devicemedical device subscriptionwearable migraine deviceprescription medical deviceheadache treatmentmigraine tracker apptelehealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

eNeura Comparables

Compare eNeura with similar companies based on industry and business-model similarity.

eNeura comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cefaly Technology
84%
Neurolief
82%
electroCore
79%

eNeura Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DFeb 6, 2018
Series CMar 10, 2016
Series BAug 28, 2014
Series A ExtensionAug 19, 2013
Series ANov 8, 2012
VC Round
Jan 11, 2010

Key People

Founding team and executive leadership

Spencer Segura

Chief Executive Officer

Executive Team

Teresa Kazaros

Chief Executive Officer

Executive Team

eNeura Investors

Notable investors and investment history

eNeura investors
InvestorRounds
Abell FoundationSeries D
Catalio Capital ManagementSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 8, 2025

    Grew 80% QoQ from 5 to 9 employees.

  • Apr 4, 2025

    Grew 60% QoQ, from 5 to 8 employees.

eNeura Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

eNeura Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about eNeura's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range11
Year Founded2000
Last FundingFeb 6, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?